| Literature DB >> 33243673 |
Antonio Rodán1, Elena Candela Marroquín1, Laura C Jara García1.
Abstract
The purpose of our work is to do an update of recent investigations about amblyopia treatment based on perceptual learning, dichoptic training and videogames. Therefore, we conducted a search of the studies published about this subject in the last six years. The review shows that the investigations during that period have used several kinds of treatments regarding their design (e.g., type of stimulus and context used, duration of the training), and in a wider range of age that also include adults. Most of the studies have found an improvement in some mono and binocular visual functions, such as visual acuity, contrast sensitivity and stereopsis, which for now, it seems advisable that these processes could be used, as an alternative or a complement of the traditional passive therapy. Nevertheless, it would be plausible to conduct additional, controlled and random, clinical trials in order to discover in a more deeply way which perceptive learning method of treatment is more effective for the improvement of visual functions and for how long the effects of the treatment could persist.Entities:
Keywords: Amblyopia; Dichoptic therapy; Perceptual learning; Videogames
Mesh:
Year: 2020 PMID: 33243673 PMCID: PMC8712591 DOI: 10.1016/j.optom.2020.08.002
Source DB: PubMed Journal: J Optom ISSN: 1989-1342
Fig. 1Flow chart for article selection process.
Methodological characteristics of studies included in the review.
| Study | Sample type and size | Intervention | Characteristics of the PL group | Outcome measure |
|---|---|---|---|---|
| Hess et al., | N = 14 Age range: 13–50 years Type of amblyopia: A(n = 7), S(n = 5), C(n = 2) | VG ( Duration of exposure (both): 10 h to 30 h Home (both) | Antisuppression DT (lenticular screen / anaglyphic version) PVG (Tetris) | VA Stereo acuity |
| Mansouri et al., 2014 | N = 22 Age range: 5–73 Mean age: 36.2 ± 20.3 years Type of amblyopia: A(n = 7), S(n = 15) | Random dot kinematograms were presented dichoptically to identify the direction of motion of the targets Duration of exposure: 2 h/session, 1000 trials/session, 18 sessions, 6 weeks (total: 36 h) Laboratory / Clinic | Antisuppression DT (video stereo-google) Motion identification task (initial contrast of the target and noise dots is 100% and 0% respectively) | VA |
| Xi et al., | N = 11 Mean age: 21.1 ± 5.1 years Age range: 11–27 years Type of amblyopia: A(n = 8), I(n = 3) | Different texture anaglyphs with different disparities with red/green glasses Duration of exposure: 10–13 sessions Laboratory / Clinic | Stereopsis (anaglyph textures) | Disparity threshold Stereo acuity VA |
| Zhang et al., 2014 | N = 19 Mean age: 22.5 years Age range: 19–27 years Type of amblyopia: A(n = 12), S(n = 2), C(n = 5) | Gabor stimulus. Configurations for contrast, orientation and Vernier discrimination at one orientation 2 stages: low and high spatial frequency Duration of exposure: 2 h/session, 30 sessions (total: 60 h) Laboratory / Clinic | MT Grating contrast detection (Gabor patch) | VA Stereo acuity CS (untrained orthogonal orientation) |
| Birch et al., | N = 50 Mean age: 5.6 ± 0.9 years Type of amblyopia: A(n = 16), S(n = 11), C(n = 23) | Binocular iPad games + patching (n = 45) Sham iPad games + patching (control) (n = 5) Duration of exposure (both): iPad: 4 h/week, 4 weeks (total: 16 h); patching: 2 h/day at a different time of game Laboratory / Clinic (both) | Antisuppression DT (anaglyphic version) PVG (Game pieces: blocks, balloons, balls, paddles) | VA Stereo acuity |
| Khan et al., 2015 | N = 61 Age range:12–30 years Mean age:17 years Type of amblyopia: A(n = 61) | Occlusion therapy of better eye with on near visual task (VG, computers, mobile phone gaming, colouring patterns) Duration of exposure: 2−4 h/day, end-point of therapy was considered as stable VA maintained at least three months of occlusion Home | MT Near visual task (VG an others) | VA |
| Li SL et al., | N = 8 Mean age = 7.4 ± 2.0 years Age range = 4–10 years Type of amblyopia: A(n = 3), S(n = 1), C(n = 4) | Watching 3 dicoptic movies per week, 2 weeks on a passive 3D screen Duration of exposure: 9.4 ± 0.9 h Laboratory / Clinic | Antisuppression DT (polarized version) Movie viewing | V Stereo acuity Interocular suppression |
| Li J et al., | N = 30 Mean age = 22.2 ± 3.5 years Age range = 17–31 years Type of amblyopia: A(n = 20), S(n = 9), C(n = 1) | Dichoptic VG presented on iPod touch equipped with a lenticular overlay screen combined with tDCS (n = 15) Dichoptic VG viewed through video goggles combined with MT (n = 15) Duration of exposure (both): 5 days/week, 2 weeks Laboratory / Clinic (both) | MT + Antisuppression DT (video googles) tDCS + Antisuppression DT (lenticular screen) PVG (falling blocks) | VA Stereo acuity CS |
| Verdamurthy et al., | N = 23 Mean age = 39.57 ± 15.74 years Age range = 19–62 years Type of amblyopia: A(n = 10), S(n = 13) | Dichoptic action VG ( Duration of exposure: 40 h Laboratory / Clinic | Antisuppression DT (stereoscope) PAVG (first-person shooter with Gabor patch). | VA Stereo-sensivity (1/arc seconds) Gabor resolution acuity Index for suppression (IOR): 0 indicates complete suppression 1 indicates no suppression |
| Verdamurthy et al., | N = 38 Mean age = 39.7 ± 15.4 years Age range = 19–66 years Type of amblyopia: A(n = 16), S(n = 22) | Dichoptic VG (n = 23) Monocular movies with patching (n = 15) Duration of exposure (both): 40 h, in sessions lasting 1.5–2 h, 2–5 times/week Laboratory / Clinic (VG group/movie group) Home (movie group) | Antisuppression DT (stereoscope) PAVG (first-person shooter with Gabor patch) Monocular viewing of action movies | VA Stereo acuity CS Reading speed Self-report of amblyopia state |
| Chen et al., | N = 13 (PL group) Mean age = 18.07 ± 7.84 years Type of amblyopia: A(n = 13) N = 10 (Patching group, test-retest) Mean age = 10.46 ± 3.08 years Type of amblyopia: A(n = 10) | Psychophysical suprathreshold binocular summation tasks within one log-unit from their cut-off spatial frequencies. Duration of exposure: 7–12 days, 10 session/day and 70–100 trials/session (total: 5000–10,000 trials, ≈8 h) Laboratory / Clinic | MT Grating contrast detection | CS Binocular function Binocular phase combination Dichoptic global motion coherence |
| Dadeya & Dangda, | N = 40 Mean age: 6.03 ± 1.14 years Type of amblyopia: A(n = 40) | Group A (control): patching alone (n = 20) Group B (study): play action VG along with patching (n = 20) Duration of exposure (both): 30 min/week, 12 weeks (total: 6 h) Laboratory / Clinic (PAVG group) | MT Television PAVG (car racing, Battle City, Mario) with hand-eye coordination | VA Stereo acuity |
| Herbison et al., 2016 | N = 75 Age range: 4–8 years Type of amblyopia: A(n = 5), S(n = 24), C(n = 46) | I-BiTgame I-BiT DVD Non-I-BiT game (control group) Duration of exposure (all): 30 min/week, 6 weeks (total: 3 h) Laboratory / Clinic | Antisuppression DT (interactive binocular game, I-BiT game) PAVG (shooter game) Antisuppression DT (interactive binocular DVD, I-BiT DVD) | VA Stereo acuity |
| Holmes et al., 2016 | N = 385 Mean age: 8.5 ± 1.9 years Type of amblyopia: A(n = 199), S(n = 66), C(n = 120) | Binocular VG in iPad (n = 190) Patching (n = 195) Duration of exposure: VG: 1 h/day; patching: 2 h/day (both: 16 weeks) Home | Antisuppression DT (anaglyphic version) PVG (falling blocks) | VA Stereo acuity |
| Kelly et al., | N = 28 Mean age: 6.7 ± 1.4 years Age range: 4.6–9.5 years Type of amblyopia: A(n = 14), S(n = 9), C(n = 5) | Binocular adventure VG iPad ( Patching group (n = 14) Duration of exposure (both): 2 h/day, 7 days/ week, 2 weeks (total: 28 h) Home (both) | Antisuppression DT (anaglyphic version) PAVG (oriented adventure) | VA Stereo acuity Suppression scotoma |
| Verdamurthy et al., | N = 11 Mean age = 34.7 years Age range = 19–56 years Type of amblyopia: A(n = 2), S(n = 4), C(n = 5) | Crush a dichoptic virtual insect in an area at an angle, hitting it with a manual physical cylinder Duration of exposure: 360 trials/session, 35 sessions (8–11 weeks) Laboratory / Clinic | Antisuppression DT with stereocopic cues (VR) PVG (natural visuomotor task: a ‘bug squashing’ game) | Interocular suppression Stereo acuity VA Vergence control |
| Barollo et al., 2017 | N = 10 Age range = 7–53 years Type of amblyopia: A(n = 2), S(n = 5), C(n = 1), others (n = 2) N = 10 (controls, non amblyopic) Age range = 7.0–51 years | Training in contrast detection (Gabor patch) Duration of exposure: 21–93 sessions (16–43 weeks) Laboratory / Clinic + Home | MT Grating contrast detection (Gabor patch) | CS AV Foveal crowding |
| Bossi et al., 2017 | N = 22 Age range = 3–11 years Mean age: 6.6 ± 2.9 years Type of amblyopia: A(n = 7), S(n = 6), C(n = 9) | Viewing of dichoptic movies and gameplay wearing goggles Group 1: A; Group 2: S + C Duration of exposure: group 1: 8 weeks; group 2: 24 weeks (both: 1 h/day) Home | Antisuppression DT (shutter glasses) Viewing movies | VA Stereo acuity Interocular suppression |
| Singh et al., | N = 68 Mean age: 10 ± 2 years Type of amblyopia: A(n = 68) | VG + occlusion (n = 34) Duration of exposure: VG: 1 h/day, 1 month (total: 30 h); occlusion: 6 h/day, 3 months (total: 540 h) Home Occlusion (n = 34) Duration of exposure: 6 h/day, 3 months (total: 540 h) Home | PAVG (Monocular viewing) | VA Stereo acuity CS |
| Žiak et al., | N = 17 Mean age = 31.2 years Age range = 17–69 years Type of amblyopia: A(n = 17) | 2 different DT games Duration of exposure: 8 sessions, 20 min/game, 40 min/session (total≈5.5 h) Laboratory / Clinic | Antisuppression DT (VR) PAVG (flying spaceship)+PVG (block breaker) | VA Stereo acuity |
| Gambacorta et al., 2018 | N = 21 Age range = 7–17 years Mean age = 9.95 ± 3.14 years Type of amblyopia: A(n = 12), S(n = 9) | Dichoptic VG (n = 10) Monocular VG (n = 11) Duration of exposure (both): 20 h Laboratory / Clinic (both) | Antisuppression DT (stereoscope) PAVG (game worlds) MT PAVG (game worlds) | VA Stereo acuity |
| Gao et al., 2018 | N = 115 Age range = 7–55 years 7−12 years (n = 45) 13−17 years (n = 17) ≥18 years (n = 53) Active group (n = 56): Mean age = 22.1 ± 13.9 years Placebo (n = 59): Mean age = 21.0 ± 13.4 years Years Type of amblyopia: A(n = 37), S (n = 12), C(n = 61) | Active group (n = 56) Placebo (n = 59): same VG with full contrast (no dichoptic presentation) Duration of exposure (both): 1 h/day, 6 weeks Home (both) | Antisuppression DT (anaglyphic version) PVG (falling blocks) on iPod Touch | VA Stereo acuity Interocular suppression Quality of life questionnaire |
| Jia et al., | N = 19 Mean age = 18.5 ± 1.26 years Type of amblyopia: A(n = 19) | MT close to its cut off spatial frequency Duration of exposure: 630 trials/day, 6–10 days Laboratory / Clinic | MT Grating contrast detection | VA CS Stereo acuity Supression |
| Kelly et al., 2018 | N = 41 Mean age = 7.0 ± 1.8 years Age range = 4.4–10.7 years Type of amblyopia: A(n = 21), S(n = 6), C(n = 14) | Game group: binocular adventure VG iPad ( Duration of exposure: 1 h/day, 5 days/week, 2 weeks (total: 10 h) Home Movie group: watch binocular movie (n = 21) Duration of exposure: 6 sessions, 2 weeks (total: 9 h) Laboratory | Antisuppression DT (anaglyphic version) PAVG (oriented adventure) Antisuppression DT (polarized version) Movie viewing | VA Stereo acuity Extent of suppression Depth of suppression |
| Liu & Zhang, | N = 13 (who completed previous study, Zhang et al., 2014) Mean age = 24 years Age range = 21–29 years Type of amblyopia: A(n = 9), S(n = 1), C(n = 3) | Gabor stimulus. Configurations for contrast, orientation and Vernier discrimination DT (after MT in previous study) Duration of exposure: 2 h/session, 9 sessions (total: 18 h) Laboratory / Clinic | Antisuppression de-masking DT (stereoscope with Gabor patch) | VA Stereo acuity CS |
| Manh et al., | N = 100 Mean age: 14.3 ± 1.1 years Type of amblyopia: A(n = 100) | Binocular VG iPad group (n = 40) Duration of exposure: 1 h/day (16 weeks) Home Patching group (n = 60) Duration of exposure: 2 h/day (16 weeks) Home | Antisuppression DT (anaglyphic version) PVG (falling blocks) | VA |
| Mezad-Koursh et al., 2018 | N = 27 Age range = 4–8 years Mean age: 5 years Type of amblyopia (treatment group): A(n = 7), S(n = 13), C(n = 7) | BinoVision (training group) (n = 19) Duration of exposure: 60 min/day, 6 days/week, 8−12 weeks (total: 48−72 h) Sham iPad games, equal stimuli for both eyes (control) (n = 8) Duration of exposure: 60 min/day, 6days/week, 4 weeks (total: 24 h) Home | Antisuppression DT (BinoVision high-tech goggles) Viewing movies or TV programs | VA Stereo |
| Moret et al., 2018 | N = 20 Age range = 27–58 years Type of amblyopia: A(n = 20) | Contrast-detection behavioural training using the lateral masking paradigm + + hf-tRNS (n = 10) + Sham stimulation (control) (n = 10) Duration of exposure (behavioural training): 8 sessions, 45 min/session, 2 weeks (total: 6 h/3840 trials) Duration of exposure (stimulation): 25 min (both groups) Laboratory / Clinic | MT Grating contrast detection (Gabor patch) | VA CS |
| Portela et al., | N = 32 Age range = 7–14 years Type of amblyopia: Ani and/or strab A(n = 2), S(n = 18), C(n = 10) | Experimental group (n = 16): initial stimulation interval depended on the value of the stereopsis at baseline. Comparison group (n = 16): stimulation interval was constant from 840 to 750″. Duration of exposure (both): 5 sessions/week, 12 weeks or less, 4800 responses, 60 sessions (total: 8 h) Home (both) | Stereopsis (Random Dot Stimuli) PVG | Stereo acuity |
| Holmes et al., | N = 138 Mean age = 9.6 years Age range = 7–12 years Type of amblyopia: A(n = 66), S(n = 26), C(n = 46) | Binocular adventure VG iPad ( Spectacle correction alone (control) (n = 69) Duration of exposure (both): 1 h/day, 5 days/week, 8 weeks (total: 40 h) Home (both) | Antisuppression DT (anaglyphic version) PAVG (oriented adventure) | VA Stereo acuity Cover test |
| Law & Backus 2019 | N = 19 Mean age = 27.9 years Age range = 16–50 years Type of amblyopia: A(n = 17), C(n = 2) | Mixed-contrast (n = 9): higher contrast to the amblyopic eye. Fixed-contrast (n = 10): contrast was the same in both eyes. Duration of exposure (both): 10 weeks, 45′/session, 10 sessions, 160 trials/session (total: 1600 trials, ~7.5 h) Laboratory / Clinic (both) | Antisuppression DT with stereocopic cues (stereoscope) | Composite stereodepth (CSD) score: mapped stereoacuity thresholds and percent correct on highdisparity trials onto a single range of 0–20. Scores from 0 to 13.3 are given over to stereoacuity values, and scores from 13.3–20 are given over to percent correct. |
| Liu & Zhang, | N = 11 Mean age = 23 years Age range = 19–28 years Type of amblyopia: A (n = 8), C(n = 3) | Gabor stimulus. Configurations for contrast and orientation discrimination Group 1 (n = 6): contrast training and then orientation exposure; Group 2 (n = 5): orientation exposure and then contrast training A subset of participants (n = 6) then performed orientation MT (9 sesions). Duration of exposure (DT): 2 h/session; 800~1000 trials/session (5 sessions; total: 10 h) Duration of exposure (MT): 2 h/session; 800~1000 trials/session (9 sessions; total: 18 h) Laboratory / Clinic (both) | Antisuppression de-masking‡ DT (stereoscope with Gabor patch) Antisuppression DT (stereoscope with Gabor patch) + MT ‡ discounting the masking effect from a noise masker presented to the fellow-eye | VA Stereo acuity CS |
| Sauvan et al., 2019 | N = 17 Mean age = 34 years Age range = 9–67 years Type of amblyopia: A (n = 11), S( n = 2), C(n = 4) | DT or nonpatched group (n = 10) Patched group (n = 7) (patching over AE two hours prior to each DT) Duration of exposure (both): 6 sessions, 1.5 h/sesión (total: 9 h) Laboratory / Clinic (both) | Antisuppression DT (polarized version) Movie viewing | VA Stereo acuity Interocular suppression |
| Birch et al., 2020 | N = 48 Mean age = 6.8 ± 1.8 years Age range = 4.3–10.8 years Type of amblyopia: A (n = 27), S + C(n = 21) | Game group: binocular adventure VG iPad ( Duration of exposure: 1 h/day, 5 days/week, 2 weeks (total: 10 h) Home Patching group (n = 24) Duration of exposure: 2 h/day, 7 days/week, 2 weeks (total: 28 h) Home | Antisuppression DT (anaglyphic version) PAVG (oriented adventure) | VA Stereo acuity Extent of suppression |
| Gu et al., 2020 | N = 46 Mean age = 15.9 ± 4.0 years Age range = 12–25 years Type of amblyopia: A (n = 46) N = 12 Mean age = 24.4 ± 3.2 years Age range = 21–30 years Normal vision | MT + patching (n = 27) Duration of exposure: MT: 10 sessions/day, 70~100 trials/sessions, 7–14 days (total: 5,000−10,000 trials, 8 h); patching: 2 h/days, 7−14 days. Laboratory / Clinic Patching group (n = 5) Duration of exposure: patching: 2 h/day, 10−13 days Home | MT Grating contrast detection ( Gabor patch) | VA CSF Stereo acuity Interocular balance SSVEPs |
anisometropic amblyopia; AE: amblyopic eye; BiT: binocular treatment; C: combined mechanism amblyopia (i.e., strabismic and anisometropic); cpd: cycles per degree; CS: contrast sensitivity; DT: dichoptic therapy; h: hour/ hours; hf-tRNS: high-frequency transcranial random noise stimulation; I: isometropic; IOR: interocular ratio; min: minutes; MT: monocular training; PL: perceptual learning; S: strabismic amblyopia; SSVEPs: Steady-state visually evoked potentials; tDCS: transcranial direct current stimulation; VA: visual acuity; VG: video game; VR: virtual reality. "Both" refers applied equally to both groups.
Most relevant results, conclusions and limitations of studies included in the review.
| Study | Results | Limitations / recomendations exposed by the authors | Compliance |
|---|---|---|---|
| Hess et al., 2014 | Binocular perception improved in 13 of 14 cases VA: 1.1 lines Stereo: 0.61 log units The anaglyph and lenticular platforms were equally effective | Unspecified | Considerable variability, 9 of 14 (85.7%) achieving close to the expected levels or above expected levels |
| Mansouri et al., 2014 | VA: 3.4 lines Follow-up (6 months): Improvement VA is maintained Increased significantly as a function of the number of sessions completed (r2 = 0.27 | It would be necessary to determine the number sessions to maximize the result and the minimum number of sessions needed to treatment | Although no compliance data is provided, pre-post results of the 22 participants are presented, so it is understood that all of them completed the training. Mean 146 sessions over a period of 4–6 weeks |
| Xi et al., 2014 | VA: 0.9 lines Stereo: 200.3″ to 81.6″ Disparity threshold: 776.7″ to 490.4″ 2 of the 3 subjects reevaluated maintained the effects in VA and stereo at 5 months reevaluation | Unspecified | Although no compliance data is provided, pre-post results of the 11 participants are presented, so it is understood that all of them completed the training |
| Zhang et al., 2014 | VA: 1.55 lines Stereo: 53% CS: specially on high spatial frequencies near the cutoff frequency | Unspecified | All participants completed the first stage. Only a subset of them (63.15%) completed the second stage. 58.33% completed training at an oblique orientation |
| Birch et al., 2015 | VA: 0.2 linesns (Sham iPad); 0.9 lines Stereo acuity: (ns) | Not a randomized clinical trial, cohort study Patching at a different time was allowed, which can be a confussion factor | Binocular iPad game play time of 16 h was reported to be ≥50% by 62% of the participants |
| Khan et al., 2015 | VA: 6 lines | Small sample size Short follow-up time | Although no compliance data is provided, pre-post results of the 61 participants are presented, so it is understood that all of them completed the training |
| Li SL et al., 2015 | VA: 2.0 lines Suppressionns Stereons | Small sample size Anecdotal nature of the data, it is not possible to draw firm conclusions | All children completed the study |
| Li J et al., 2015 | CS: improved across all spatial frequencies tested for both groups No significant correlation between the change in CS and changes in VA or suppression in neither group | Data were combined from two different studies that used different experimental designs Both groups of participants were not directly matched in terms of age and amblyopic eye VA CS measured at a relatively high mean luminance | Although no compliance data is provided, pre-post results of the 30 participants are presented, so it is understood that all of them completed the training |
| Verdamurthy et al., 2015a | VA: 1.4 lines Stereo (1/arcsec): 0.007* CS: 3.07 cpd IOR increased by a factor of ≈1.6, indicating a reduction in suppression The reduction in suppression was not significantly correlated with the improvement in the visual function Stereopsis improved in 9 subjects (39%), of 200 in 20 arcseg (a 10 factor) | The participants were “A” and “S” amblyopic patients, it would be necessary to conduct a randomized clinical trial in a large population of amblyopia to determine the most effective method according to the type of amblyopia | Compliance data unespeficied |
| Verdamurthy et al., 2015b | VA: 1.4 lines VA (difference between groups): 0.7 lines Stereo acuity: Overall significant change CS: Overall significant change No effect for timeXgroup in reading speedns Most improvements were largely retained following a 2-month no-contact period | Dichoptic VG intervention required that subjects receive extensive training (40 h) in the laboratory, which resulted in a large drop-out rate (38%) | Drop-out rate 38% vs 28% in VG group and movie group, respectively |
| Chen et al., 2016 | VA (PL group): 1.64 lines CS (PL group): Significantly improved Stereo (PL group): Increases significantly | Test-retest reliability was assessed in a patching group instead of a non-intervention group because of the regulation of clinical practice There were not well matched in terms of age and interventional periods between both groups Patching could be considered as a confounding factor (too short-term monocular deprivation) | Compliance data unespeficied |
| Dadeya & Dangda, 2016 | VA: 2.9 lines VA (difference between groups): 1.3 lines Stereo acuity: (Group A): 5 subjects had 200 arcseg; (group B): 7 subjects had 100 arcseg | Small sample size Short duration of exposure Initial dropouts have been excluded from analysis Lack of objectively recorded compliance at home for both groups | Compliance to the VG was fully ensured as the examiner was present throughout the session and monitored each child |
| Herbison et al., 2016 | VA: ≈ 0.7 lines in all three groups at 6 and 10 weeks VA (difference between groups): No difference between I-BiT DVD (1 line) and non-I-BiT games (0.3 lines) compared with I-BiT games (0.6 lines) in terms of gain in visionns Stereo: No significant changes in any of the three groupsns | Short duration of treatment, and duration and frequency of the sessions High proportion of patients with strabismic (93%) and residual amblyopia (89%) | With each of the treatments was excellent (>90%) with the majority of participants playing the game/watching the DVD for 30 min at each session |
| Holmes et al., 2016 | VA: 1.05 lines (binocular); 1.35 lines (patching) VA (difference between groups): 0.3 linesns VA (5 to <7 years without prior amblyopia treatment): 2.5 lines (binocular) and 2.8 lines (patching) Stereo: did not differ significantly between treatment groups for the overall cohort or for participants with no history of strabismus at baseline | Compliance data were monitored by the parent's report for the patching group and for the time connected to the game for the game group. In both cases there could be errors in compliance monitoring Compliance with the use of the red-green glasses required to play the game was not monitorized | 22% achieved greater than 75% compliance. See “limitations” |
| Kelly et al., 2016 | VA: 1.5 lines VA (difference between groups): 0.8 lines No differences between the binocular game vs patching treatments for change in stereons, extent of suppressionns and depth of suppressionns | Small sample size. Short duration of treatment, it is necessary to analized the effects of treatment in the longer-term Unassessed baseline factors (ie, BCVA, age) that may be important modifiers of treatment effect | 85% (23 of 27) of children played at least 75% of prescribed treatment |
| Verdamurthy et al., 2016 | VA: just a trend for improved (p = .06) Stereo: Significant change Suppression: Significantly reduced For the stereo-deficient group, no significant differences in noise vergence measured pre-training, post-training and at follow-up (p = .36). Follow-up 2 month post-training: 5 out of 6 subjects maintained improvements in stereo | Vergence measure is a subjective measure, and not be sufficiently sensitive to detect very small changes in oculomotor control. Training was carried out in a virtual reality environment, trying to recreate a natural environment. | Compliance data unespeficied |
| Barollo et al., 2017 | VA: 1.8 lines Vernier acuity: just a trend for improved (p = .06) Reduction of crowding CS: Significant change at intermediate spatial frequencies (7 cpd) after PL | A direct comparison can not be made with previous results | Compliance data unespeficied |
| Bossi et al., 2017 | VA (overall): 2.7 lines VA (group 1): 2.6 lines VA (group 2): 2.7 lines VA (difference between groups)ns Stereo (group 1): Improvement was 165 ± 182″ Suppressión: no reductionns | Treatment duration varied across children Small sample size | Compliance (calculated as the percentage of days when treatment was received) was 68.0 ± 12.2%. On average, 89.4 ± 24.2% of daily dose (54′/day; total: 75 h) |
| Singh et al., 2017 | VA: 1 line VA: 2.1 line VA (difference between groups): 0.5 lines | Long-term studies with weaning of occlusion therapy may be required to assess for the recovery of stereo | Patients who failed to follow-up at 1 month or follow the prescribed therapy or who had poor compliance were excluded. No further data specified |
| Žiak et al., 2017 | VA: 1.5 lines Stereo: 263.3 ± 135.1–176.7 ± 152.4 arcseg | Small sample size Short follow-up Absence of a control group Stereo test used measures values of 400″ as max. | Although no compliance data is provided, pre-post results of the 17 participants are presented, so it is understood that all of them completed the training |
| Gambacorta et al., 2018 | VA: 1.4 lines (≈38%) (DT group); 0.6 lines (≈15%) (MT group) VA (difference between groups): 0.8 lines (3.14) VA: 1.1 lines (A) and 0.7 (S) (Cohen's Stereo: improved ≈17% (DT) and ≈15% (MT) (0.1)a Follow-up 6−10 weeks pos-training: VA and stereo improvements were maintained in 57% of the participants at follow-up | General dropout rate of 28% perhaps due to visits to the laboratory (2–3 times per week). Small sample size | 21 of 29 subjects (72%) completed 20 h of training under supervision with number of weeks to completion varying widely between participants (from 3 to 20 weeks) Drop-out rate was about 31% for the MT group and 23% for DT group |
| Gao et al., 2018 | VA: 0.6 linesns (active group); 0.7 linesns (placebo group). VA (difference between groups)ns No difference for changes of any secondary outcomes were found between both groups ns | Unable to monitor participants’ attention to the video game at home or whether they wore anaglyphic glasses correctly. | Compliance with more than 25% (≥10.5 h) was achieved in 64% (active group) and 83% (placebo group) of participants |
| Jia et al., 2018 | VA: 1.7 lines CS: an improvement of 278.4% at the trained spatial frequency Stereo: 929.11″ to 80.42″ Suppressionns Dominance duration ratio (amblyopic eye): 9%–15% | Training time too short | Compliance data unespeficied |
| Kelly et al., 2018 | VA:1.4 lines Stereo: Significant change Suppression: Extent/depth of suppression were reduced Depth of suppression was reduced more in children aged <8 years than in those aged ≥8 years | Pooled data from two ongoing studies of binocular treatment and was limited in that there was no control group | Game group: 87% prescribed treatment time |
| Liu & Zhang, 2018 | VAns Stereo: 146.9″ to 103.1″ Maximal tolerable noise contrast Improvements persist for 10 months after DT in 54% cases | Results based on 70% of cases with type A amblyopia Results may be specific to the training used Small sample size, and not run a control group | Although no compliance data is provided, pre-post results of the 13 participants are presented, so it is understood that all of them completed the training |
| Manh et al., 2018 | VA: 0.74 lines (binocular group); 1.26 lines (patching group) VA (difference between groups): 0.52 linesns | Poor treatment adherence | Binocular group (data from the iPad device for 97% of participants): 13% of participants completed >75% of the prescribed treatment |
| Mezad-Koursh et al., 2018 | VA (training group, 12 weeks): 2.6 lines VA (control group, 4 weeks)ns VA (difference between groups) VA (training group, follow-up 24 weeks): remained stable Improvement is greater the longer the treatment time | Nonrandomized study Small sample size Most subjects were previously treated and had residual amblyopia No compare the effectiveness on different types of amblyopia | All 19 patients in the treatment group completed 8 weeks of treatment; 16 (84%) completed 12 weeks of treatment. |
| Moret et al., 2018 | VA (training group): 1.9 lines VA (control group)ns VA (difference between groups) VA (training group, follow-up 6 months): remained stable CS: significantly improved in both groups CS (difference between groups)ns | unespeficied | Although no compliance data is provided, pre-post results of the 20 participants are presented, so it is understood that all of them completed the training. |
| Portela et al., | Stereo: Improvement with RPST was 50% (RPST) and 46.42% (Wirt Circles) and it was statistically different when success was considered a gain of two levels on Wirt Circles and stereoacuity 140″ or less Stereo remained stable after 6 months when measured with RPST | Computer and software settings: stimulation category be set manually, but it should be automatic according to the patient's evolution Martín et al., 2020 Study design: Too small sample of subjects with type A amblyopia; age range was restricted to 7−14 years; the stereoacuity range was between 800"-200" Martín et al., 2020 | 100% compliance was considered if patients finished the training in less than 12 weeks (5 sessions/week). Compliance was excellent, with a median percentage value of 88.36% |
| Holmes et al., 2019 | VA (4 weeks): 0.26 lines (binocular group); 0.34 lines (control group) VA (difference between groups): 0.08 linesns No difference for changes of any secondary outcomes were found between both groups ns Analyzing possible differential treatment effect by baseline characteristics, no factors were found to be statistically significant, including basal stereo acuity | Possible biases due to the lack of correct monitoring (not playing for the entire time that the handheld device recorded, not wear the red- green glasses) | Spectacle wear (across 8 weeks, >75% of time): 90% (binocular) 98% (control) PAVG (across 8 weeks, >75% of time): parent report: 75%; log file data: 56% Median total hours of game play was 31 h of the intended 40 h at 8 weeks |
| Law & Backus 2019 | 44% of participants (mixed-contrast group) showed improvement in stereodepth individually*, none (fixed-contrast group) showed improvement individuallyns Stereodepth (difference between groups) | Training relatively sparse and only 1–2 sessions per week for a total of 10 sessions. It is possible that learning would be greater with additional or more frequent training | Although no compliance data is provided, first four and last four sessions results of the 19 participants are presented, so it is understood that all of them completed the training |
| Liu & Zhang, 2019 | VA: 1.2 lines Stereo: 60.2 ± 4.9% CS: mainly at higher spatial frequencies Additional MT did not produce further AV and stereoacuity gains | Results based on >70% of cases with type A amblyopia Results may be specific to the training used Small sample size No follow-up | Although no compliance data is provided, pre-post results of the 11 participants are presented, so it is understood that all of them completed the training |
| Sauvan et al., 2019 | VA: 0.8 lines VA (difference between groups): 1.1 linesns VA (follow-up 1 month): Improvement VA is maintained only in the patched group CS, stereo, interocular suppressionns | Non-homogeneous groups Non-randomization Short period of training Better measure of stereopsis More sensitive test of binocular balance Extend the periods of occlusion to see if its benefits for DT can be enhanced | Although no compliance data is provided, pre-post results of the 17 participants are presented, so it is understood that all of them completed the training |
| Birch et al., 2020 | VA:1.5 lines (game group); 0.7 lines (patching group) VA (difference between groups):0.8 lines 35% of children of binocular game had recovered normal VA. Only 8% of the children in the patching group recovered normal VA for age Only in the game group, baseline VA and ocular alignment were associated with response to treatment (p < .001). Age, etiology, prior treatment and baseline stereo were not associated with response to treatment Dose-response: Only in the game group, moderate linear relationship between hours of game with VA improvement. 5 h (50% adherence) improved 0.1 logMAR; 10 h (100%), 0.18 logMAR; 15 h (150%) 0.26 logMAR | Single-site, small-cohort randomized clinical trial The inclusion/exclusioncriteria may limit generalization to other groups of amblyopic children VA testing was not masked Results may be dependent on the criteria chosen to dichotomize each variable The brief duration may limit improvement of VA Possible biases due to the lack of correct monitoring ( number of hours of patching objectively, not wear the red- green glasses) | Parents overestimated time spent playing the game by 13% Game group completed 10.3 ± 3.0 h (103% prescribed treatment time Patching group completed 27.7 ± 2.6 h (99% prescribed treatment time) |
| Gu et al., 2020 | VA (Due to the length of the results, it is recommended to see the "results" section in the original article) | Control group had only five subjects Training effects may be due to the influences of both training and patching Effects of patching were not entirely ruled out in this study. Further investigations with more subject and only training (no patching) are necessary | Although no compliance data is provided, pre-post results of the 32 (out of 46) participants are presented, so it is understood that not everyone completed the training |
anisometropic amblyopia; BCVA: Best corrected visual acuity; BiT: binocular treatment; cpd: cycles per degree; CS: contrast sensitivity; DT: dichoptic therapy; h: hour/ hours; IOR: interocular ratio; min: minutes; MT: monocular training; ns: no significance; PL: perceptual learning; S: strabismic amblyopia; SSVEPs: Steady-state visually evoked potentials; VA: visual acuity; VG: video game.
Cohen's “d” effect size has been calculated when the p-value is not shown in the study, but means and SD are shown (d≥0.80 is considered a large effect size)."Both" refers applied equally to both groups. The average improvement in VA lines is always referred from the baseline.
p < 0.05;
p < .01;
p < .001.
GRADE evidence profile.
| Study | Design of study | Level of evidence† | A priori quality level | Detected criteria lowering and raising‡ “a priori quality level” | |
|---|---|---|---|---|---|
| Hess et al., 2014 | Case-series study | IV | low | Indirectness: wide age range Imprecision: small sample size (per group / condition) | very low |
| Mansouri et al., 2014 | Case-series study | IV | low | Indirectness: wide age range Imprecision: small sample size (per group / condition) | very low |
| Xi et al., 2014 | Case-series study | IV | low | Indirectness: wide age range Imprecision: small sample size (per group / condition) | very low |
| Zhang et al., 2014 | Case-series study | IV | low | Indirectness: wide age range Imprecision: small sample size (per group / condition) | very low |
| Birch et al., 2015 | Cohort study | III-2 | low | Risk of bias: non randomized, non making Indirectness: patching at a different time | low |
| Khan et al., 2015 | Case-series study | IV | low | Indirectness: wide age range | very low |
| Li SL et al., 2015 | Case-series study | IV | low | Indirectness: wide age range Imprecision: small sample size (per group / condition) | very low |
| Li J et al., 2015 | Cohort study (crossover design) | III-2 | low | Risk of bias: non randomized, non making Indirectness: data were combined from two different studies that used different experimental designs; comparison group performs another type of PL–not a true control group– Imprecision: small sample size (per group / condition) | very low |
| Verdamurthy et al., 2015a | Case-series study | IV | low | Indirectness: wide age range | very low |
| Verdamurthy et al., 2015b | Cohort study | III-2 | low | Risk of bias: non randomized, non making Indirectness: wide age range; comparison group performs another type of PL–not a true control group– | low |
| Chen et al., 2016 | Cohort study | III-2 | low | Risk of bias: pseudo-randomized, non making Indirectness: wide age range Publication bias: Unreported intergroup results (control vs PL) | very low |
| Dadeya & Dangda, 2016 | Clinical trial (parallel, randomized, no masking) | II | high | Risk of bias: non making ‡ Dosis-response gradient | high |
| Herbison et al., 2016 | Clinical trial (parallel, randomized, simple-blind) | II | high | No highlights | high |
| Holmes et al., 2016 | Clinical trial (parallel, randomized, simple-blind) | II | high | Indirectness: duration of exposure in both groups is different | high |
| Kelly et al., 2016 | Clinical trial (cross-over, randomized, no masking) | II | high | Risk of bias: non making Imprecision: small sample size (per group / condition) ‡ Dosis-response gradient | high |
| Verdamurthy et al., 2016 | Case-series study | IV | low | Indirectness: wide age range Imprecision: small sample size (per group / condition) | very low |
| Barollo et al., 2017 | Cohort study | III-2 | low | Indirectness: wide age range Imprecision: small sample size (per group / condition) ‡ Dosis-response gradient | low |
| Bossi et al., 2017 | Cohort study | III-2 | low | Risk of bias: non randomized, non making Indirectness: wide age range; duration of exposure in both groups is different; both groups receive the same type of treatment–not a true control group– Imprecision: small sample size (per group / condition) | very low |
| Singh et al., 2017 | Clinical trial (parallel, randomized, no masking) | II | high | Risk of bias: non making Indirectness: duration of exposure in both groups is different ‡ Dosis-response gradient | high |
| Žiak et al., 2017 | Case-series study | IV | low | Indirectness: wide age range | very low |
| Gambacorta et al., 2018 | Clinical trial (parallel, randomized, no masking) | II | high | Indirectness: wide age range; comparison group performs another type of PL–not a true control group– | moderate |
| Gao et al., 2018 | Clinical trial (parallel, randomized, double-blind) | II | high | No highlights | high |
| Jia et al., 2018 | Case-series study | IV | low | No highlights | low |
| Kelly et al., 2018 | Clinical trial (cross-over, randomized, no masking) | II | high | Risk of bias: non making Indirectness: data were pooled from two ongoing studies (clinical trials, NTC02365090) of binocular treatment for childhood amblyopia (Kelly et al., 2016; Li et al, 2015b);comparison group performs another type of PL–not a true control group– Imprecision: small sample size (per group / condition) | moderate |
| Liu & Zhang, | Case-series study | IV | low | Imprecision: small sample size (per group / condition) | very low |
| Manh et al., | Clinical trial (parallel, randomized, simple-blind) | II | high | Indirectness: duration of exposure in both groups is different | high |
| Mezad-Koursh et al., 2018 | Cohort study | III-2 | low | Risk of bias: non randomized, non making Indirectness: duration of exposure in both groups is different Imprecision: small sample size (per group / condition) | very low |
| Moret et al., 2018 | Cohort study | III-2 | low | Risk of bias: non making Indirectness: wide age range Imprecision: small sample size (per group / condition) ‡ Dosis-response gradient | low |
| Portela et al., | Clinical trial (parallel, randomized, double-blind) | II | high | Indirectness: wide age range Imprecision: small sample size (per group / condition) ‡ Dosis-response gradient | high |
| Holmes et al., | Clinical trial (parallel, randomized, simple-blind) | II | high | No highlights | high |
| Law & Backus 2019 | Cohort study | III-2 | low | Risk of bias: non making Indirectness: wide age range; comparison group performs another type of PL–not a true control group–; Test, retest and training with the same type of task Imprecision: small sample size (per group / condition) | very low |
| Liu & Zhang, | Cohort study | III-2 | low | Risk of bias: non making Indirectness: Comparison group performs another type of PL–not a true control group– Imprecision: small sample size (per group / condition) | very low |
| Sauvan et al., 2019 | Cohort study | III-2 | low | Risk of bias: non randomized, non making Indirectness: wide age range; duration of exposure in every participant is different; comparison group performs another type of PL–not a true control group– Imprecision: small sample size (per group / condition) | very low |
| Birch et al., 2020 | Clinical trial (cross-over, randomized, no masking) | II | high | Risk of bias: non making Indirectness: enrolling two pre-planned cohorts (Kelly et al., 2016; clinical trial NTC02365090) and an additional 20 children to be combined with the primary cohort to allow for evaluation of factors that may affect treatment outcomes including baseline factors. Imprecision: small sample size (per group / condition) ‡ Dosis-response gradient | moderate |
| Gu et al., 2020 | Cohort study | III-2 | low | Risk of bias: non randomized, non making Indirectness: wide age range; it is possible that the observed training effects were due to the influences of both training and patching Imprecision: small sample size (per group / condition), specially in control group | very low |
† National Health & Medical Research Council clinical evidence hierarchies.